Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Eukaryotic translation initiation factor 4A1 pseudogene 7 (EIF4A1P7)** is classified as a **processed pseudogene** of the gene encoding eukaryotic translation initiation factor 4A1 (EIF4A1), a key DEAD-box RNA helicase critical for translation initiation[2]. EIF4A1P7 itself is located on chromosome 19q13.12 and, like other pseudogenes in this family, does **not encode a functional protein**[2]. Pseudogenes may be transcribed and can impact gene expression through mechanisms such as acting as miRNA sponges or producing regulatory RNAs, but there is **no evidence that EIF4A1P7 functions as a protein-coding gene, disease gene, or drug target**[2][5]. There is also no specific evidence for EIF4A1P7 having a direct role in disease, drug interaction, or serving clinically as a biomarker. It is important to note that confusion between the **functional EIF4A1 gene** (a translation initiation factor implicated as an oncogene and drug target in cancer) and **pseudogenes such as EIF4A1P7** should be avoided; only the parent gene, not the pseudogene, is a validated therapeutic target[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 7 (EIF4A1P7).